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Re: “Dietary fatty acids intake
and mortality in patients
with heart failure”
To the Editor:
We read with great interest the recently published article by
Colin-Ramirez et al. [1] in which the authors aimed to evaluate
the association of macro- and micronutrients intake on 1-y of
mortality in patients with heart failure (HF). The authors
concluded that intake of polyunsaturated fatty acids (PUFAs)
and saturated fatty acids (SFAs) was independently associated
with 1-y of all-cause mortality in patients with chronic HF.
Limiting dietary SFAs and increasing PUFA intakemight be advis-
able in this population [1]. However, we think that there are
some points that should be emphasized about this study.
First, in the original study, it was indicated that dietary intake
of participants was estimated by using a 3-d food record, which
has been shown to have a higher validity and agreement than the
103-item food frequency questionnaire compared with 9-d food
record. However, this 3-d record is not of long enough duration
for an opinion to be formed about the pathogenesis of cardiovas-
cular disease (CVD) or HF. Although, the importance of fatty acids
(FAs) in cellular homeostasis demands an efﬁcient uptake sys-
tem, their metabolism in cells and tissues still plays the most
important role in the pathogenesis of diseases like CVD [2].
Therefore, quantitating the level of FAs in plasma, erythrocyte
membrane, and even tissues, particularly of essential FAs, in
addition to assessing dietary intake, can provide more accurate
results about the processes leading to the pathogenesis of HF
and can provide valuable information in the management of di-
etary strategies in HF, which are deﬁcient and blamed for the
pathogenesis of CVD.
Second, to date, there have been several studies evaluating
the inﬂuence of intake of PUFAs on risk for coronary heart dis-
ease and on mortality in patients with chronic HF [3–5]. In the
original study, intake of total fat was broken down into mono-
unsaturated, PUFAs, and SFAs. PUFAs include both u-3 and u-6
FAs and a healthy diet contains a balance of both FAs. This bal-
ance is essential for cardiovascular health because, as is known,
u-6 PUFAs may compete with u-3 PUFAs for common meta-
bolic enzymes and thereby increase the production of pro-
thrombotic rather than antithrombotic and inﬂammatory
leukotrienes, thromboxanes, and prostaglandins [6,7]. Howev-
er, exploratory analyses of dietary PUFAs subtypes were not
performed in the original analysis, and this may lead to under-
estimation and undertreatment of the current patient group.
Therefore, it would have been better to evaluate different pat-
terns of u-3 and u-6 PUFA intake and ratios of intake in the
original study [8].Open access under CC BY-NC-ND license.In conclusion, measurement of the level of FAs in plasma,
erythrocyte membrane, and even tissues, and evaluation of die-
tary PUFAs subtypes are critical to assess patients with HF.
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Authors’ responseTo the Editor:
We thank Sertoglu et al. for their interest in our work, their
insightful comments, and the opportunity to clarify relevant
aspects from our work. Sertoglu et al. [1] pointed out that
the self-reported dietary method we used in our study, the
3-d food record, is not enough to justify an opinion about the
pathogenesis of cardiovascular disease (CVD) or heart failure
(HF), and that metabolism of fatty acids (FAs) in cells and tissues
plays the most important role in the pathogenesis of CVD. They
further suggested that quantifying the level of FAs in plasma
erythrocyte membrane and tissues, particularly essential fatty
acids, can providemore accurate results than dietary information
regarding the processes leading to HF.
Although our work [2] was designed to evaluate the associa-
tion of dietary intake and 1-y mortality in patients with HF, we
